AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) reached a new 52-week high on Monday . Weiss Ratings reissued a “sell (d-)” rating on shares of AngioDynamics in a research report on Friday, July 17th. Zacks Research lowered AngioDynamics from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 16th. Following the transaction, the senior vice president directly owned 64,745 shares of the company’s stock, valued at approximately $953,046.40. State of Wyoming acquired a new position in AngioDynamics in the 2nd quarter valued at $31,000.